| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.086 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.029 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |